Endomyocardial expression of SDF-1 predicts mortality in patients with suspected myocarditis

Clinical Research in Cardiology

Volumn 104, Issue 12, 2015, Pages 1033-1043

  Zuern, Christine S ^a   Walker, Britta ^a   Sauter, Martina ^a   Schaub, Malte ^a   Chatterjee, Madhumita ^a   Mueller, Karin ^a   Rath, Dominik ^a   Vogel, Sebastian ^a   Tegtmeyer, Roland ^a   Seizer, Peter ^a   Geisler, Tobias ^a   Kandolf, Reinhard ^a   Lang, Florian ^a   Klingel, Karin ^a   Gawaz, Meinrad ^a   Borst, Oliver ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Biomarker; Cardiomyopathy; Endomyocardial biopsy; Myocarditis; SDF 1

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; STROMAL CELL DERIVED FACTOR 1; TROPONIN I;

ADULT; AGED; ARTICLE; CARDIOMYOPATHY; CONTROLLED STUDY; COXSACKIE VIRUS INFECTION; ECHOCARDIOGRAPHY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HEART MUSCLE FIBROSIS; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOLOGY; INFLAMMATORY DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIXED INFECTION; MORTALITY; MYOCARDITIS; PARVOVIRUS INFECTION; PROSPECTIVE STUDY; PROTEIN EXPRESSION; RISK FACTOR; BIOPSY; CARDIAC MUSCLE; FIBROSIS; FOLLOW UP; INFLAMMATION; METABOLISM; MULTIVARIATE ANALYSIS; PATHOLOGY; RISK; SEVERITY OF ILLNESS INDEX;

ADULT; AGED; BIOPSY; CHEMOKINE CXCL12; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDITIS; MYOCARDIUM; PROSPECTIVE STUDIES; RISK; SEVERITY OF ILLNESS INDEX;

EID: 84947867570     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-015-0871-y     Document Type: Article

References (51)

1. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB, American Heart Association, Council on Clinical Cardiology, Heart Failure and Transplantation Committee, Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups, Council on Epidemiology and Prevention (2006) Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation 113:1807–1816. doi:10.1161/CIRCULATIONAHA.106.174287
2. Elamm C, Fairweather D, Cooper LT (2012) Pathogenesis and diagnosis of myocarditis. Heart 98:835–840. doi:10.1136/heartjnl-2012-301686
3. Chandra D, Kar B, Idelchik G, Simpson L, Loyalka P, Gregoric ID, Delgado RM 3rd, Frazier OH (2007) Usefulness of percutaneous left ventricular assist device as a bridge to recovery from myocarditis. Am J Cardiol 99:1755–1756. doi:10.1016/j.amjcard.2007.01.067
4. Cooper LT Jr (2009) Myocarditis. N Engl J Med 360:1526–1538. doi:10.1056/NEJMra0800028
5. Yoshizawa S, Kato TS, Mancini D, Marboe CC (2013) Outcome of patients having heart transplantation for lymphocytic myocarditis. Am J Cardiol 112:405–410. doi:10.1016/j.amjcard.2013.03.042
6. Ahmed A, Perry GJ, Fleg JL, Love TE, Goff DC Jr, Kitzman DW (2006) Outcomes in ambulatory chronic systolic and diastolic heart failure: a propensity score analysis. Am Heart J 152:956–966. doi:10.1016/j.ahj.2006.06.020
7. Michels VV, Driscoll DJ, Miller FA, Olson TM, Atkinson EJ, Olswold CL, Schaid DJ (2003) Progression of familial and non-familial dilated cardiomyopathy: long term follow up. Heart 89:757–761
8. Ukena C, Kindermann M, Mahfoud F, Geisel J, Lepper PM, Kandolf R, Bohm M, Kindermann I (2014) Diagnostic and prognostic validity of different biomarkers in patients with suspected myocarditis. Clin Res Cardiol 103:743–751. doi:10.1007/s00392-014-0709-z
9. Miller WL, Hartman KA, Burritt MF, Burnett JC Jr, Jaffe AS (2007) Troponin, B-type natriuretic peptides and outcomes in severe heart failure: differences between ischemic and dilated cardiomyopathies. Clin Cardiol 30:245–250. doi:10.1002/clc.20075
10. Nagarajan V, Hernandez AV, Tang WH (2012) Prognostic value of cardiac troponin in chronic stable heart failure: a systematic review. Heart 98:1778–1786. doi:10.1136/heartjnl-2012-301779
11. Frioes F, Lourenco P, Laszczynska O, Almeida PB, Guimaraes JT, Januzzi JL, Azevedo A, Bettencourt P (2015) Prognostic value of sST2 added to BNP in acute heart failure with preserved or reduced ejection fraction. Clin Res Cardiol. doi:10.1007/s00392-015-0811-x
12. Lok DJ, Lok SI, Bruggink-Andre de la Porte PW, Badings E, Lipsic E, van Wijngaarden J, de Boer RA, van Veldhuisen DJ, van der Meer P (2013) Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure. Clin Res Cardiol 102:103–110. doi:10.1007/s00392-012-0500-y
13. Volz HC, Laohachewin D, Schellberg D, Wienbrandt AR, Nelles M, Zugck C, Kaya Z, Katus HA, Andrassy M (2012) HMGB1 is an independent predictor of death and heart transplantation in heart failure. Clin Res Cardiol 101:427–435. doi:10.1007/s00392-011-0409-x
14. Fujita B, Franz M, Goebel B, Fritzenwanger M, Figulla HR, Kuethe F, Ferrari M, Jung C (2012) Prognostic relevance of heart rate at rest for survival and the quality of life in patients with dilated cardiomyopathy. Clin Res Cardiol 101:701–707. doi:10.1007/s00392-012-0447-z
15. Kindermann I, Kindermann M, Kandolf R, Klingel K, Bultmann B, Muller T, Lindinger A, Bohm M (2008) Predictors of outcome in patients with suspected myocarditis. Circulation 118:639–648. doi:10.1161/CIRCULATIONAHA.108.769489
16. Escher F, Vetter R, Kuhl U, Westermann D, Schultheiss HP, Tschope C (2011) Fractalkine in human inflammatory cardiomyopathy. Heart 97:733–739. doi:10.1136/hrt.2010.205716
17. Penn MS, Mendelsohn FO, Schaer GL, Sherman W, Farr M, Pastore J, Rouy D, Clemens R, Aras R, Losordo DW (2013) An open-label dose escalation study to evaluate the safety of administration of nonviral stromal cell-derived factor-1 plasmid to treat symptomatic ischemic heart failure. Circ Res 112:816–825. doi:10.1161/CIRCRESAHA.111.300440
18. Askari AT, Unzek S, Popovic ZB, Goldman CK, Forudi F, Kiedrowski M, Rovner A, Ellis SG, Thomas JD, DiCorleto PE, Topol EJ, Penn MS (2003) Effect of stromal-cell-derived factor 1 on stem-cell homing and tissue regeneration in ischaemic cardiomyopathy. Lancet 362:697–703. doi:10.1016/S0140-6736(03)14232-8
19. Bromage DI, Davidson SM, Yellon DM (2014) Stromal derived factor 1alpha: a chemokine that delivers a two-pronged defence of the myocardium. Pharmacol Ther 143:305–315. doi:10.1016/j.pharmthera.2014.03.009
20. Rath D, Chatterjee M, Borst O, Muller K, Stellos K, Mack AF, Bongartz A, Bigalke B, Langer H, Schwab M, Gawaz M, Geisler T (2014) Expression of stromal cell-derived factor-1 receptors CXCR4 and CXCR7 on circulating platelets of patients with acute coronary syndrome and association with left ventricular functional recovery. Eur Heart J 35:386–394. doi:10.1093/eurheartj/eht448
21. Wurster T, Tegtmeyer R, Borst O, Rath D, Geisler T, Gawaz M, Bigalke B (2014) Platelet expression of stromal cell-derived factor-1 is associated with the degree of valvular aortic stenosis. PLoS One 9:e97405. doi:10.1371/journal.pone.0097405
22. Ziegler M, Elvers M, Baumer Y, Leder C, Ochmann C, Schonberger T, Jurgens T, Geisler T, Schlosshauer B, Lunov O, Engelhardt S, Simmet T, Gawaz M (2012) The bispecific SDF1-GPVI fusion protein preserves myocardial function after transient ischemia in mice. Circulation 125:685–696. doi:10.1161/CIRCULATIONAHA.111.070508
23. Ceradini DJ, Kulkarni AR, Callaghan MJ, Tepper OM, Bastidas N, Kleinman ME, Capla JM, Galiano RD, Levine JP, Gurtner GC (2004) Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med 10:858–864. doi:10.1038/nm1075
24. Saxena A, Fish JE, White MD, Yu S, Smyth JW, Shaw RM, DiMaio JM, Srivastava D (2008) Stromal cell-derived factor-1alpha is cardioprotective after myocardial infarction. Circulation 117:2224–2231. doi:10.1161/CIRCULATIONAHA.107.694992
25. Stellos K, Langer H, Daub K, Schoenberger T, Gauss A, Geisler T, Bigalke B, Mueller I, Schumm M, Schaefer I, Seizer P, Kraemer BF, Siegel-Axel D, May AE, Lindemann S, Gawaz M (2008) Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation 117:206–215. doi:10.1161/CIRCULATIONAHA.107.714691
26. Geisler T, Fekecs L, Wurster T, Chiribiri A, Schuster A, Nagel E, Miller S, Gawaz M, Stellos K, Bigalke B (2012) Association of platelet-SDF-1 with hemodynamic function and infarct size using cardiac MR in patients with AMI. Eur J Radiol 81:e486–e490. doi:10.1016/j.ejrad.2011.06.019
27. Stellos K, Bigalke B, Langer H, Geisler T, Schad A, Kogel A, Pfaff F, Stakos D, Seizer P, Muller I, Htun P, Lindemann S, Gawaz M (2009) Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells. Eur Heart J 30:584–593. doi:10.1093/eurheartj/ehn566
28. Subramanian S, Liu C, Aviv A, Ho JE, Courchesne P, Muntendam P, Larson MG, Cheng S, Wang TJ, Mehta NN, Levy D (2014) Stromal cell-derived factor 1 as a biomarker of heart failure and mortality risk. Arterioscler Thromb Vasc Biol 34:2100–2105. doi:10.1161/ATVBAHA.114.303579
29. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R, American Heart Association, American College of Cardiology, European Society of Cardiology (2007) The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation 116:2216–2233. doi:10.1161/CIRCULATIONAHA.107.186093
30. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, McDonagh T, Sechtem U, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P, ESC Committee for Practice Guidelines (2012) ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 14:803–869. doi:10.1093/eurjhf/hfs105
31. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R (2004) Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol 193:101–107. doi:10.1007/s00430-003-0190-1
32. Mahrholdt H, Wagner A, Deluigi CC, Kispert E, Hager S, Meinhardt G, Vogelsberg H, Fritz P, Dippon J, Bock CT, Klingel K, Kandolf R, Sechtem U (2006) Presentation, patterns of myocardial damage, and clinical course of viral myocarditis. Circulation 114:1581–1590. doi:10.1161/CIRCULATIONAHA.105.606509
33. Richardson P, McKenna W, Bristow M, Maisch B, Mautner B, O’Connell J, Olsen E, Thiene G, Goodwin J, Gyarfas I, Martin I, Nordet P (1996) Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 93:841–842
34. Kawai C (1999) From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 99:1091–1100
35. Rutschow S, Li J, Schultheiss HP, Pauschinger M (2006) Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res 69:646–656. doi:10.1016/j.cardiores.2005.12.009
36. Zuern CS, Muller KA, Seizer P, Geisler T, Banya W, Klingel K, Kandolf R, Bauer A, Gawaz M, May AE (2013) Cyclophilin A predicts clinical outcome in patients with congestive heart failure undergoing endomyocardial biopsy. Eur J Heart Fail 15:176–184. doi:10.1093/eurjhf/hfs185
37. Tanaka M, Fujiwara H, Onodera T, Wu DJ, Hamashima Y, Kawai C (1986) Quantitative analysis of myocardial fibrosis in normals, hypertensive hearts, and hypertrophic cardiomyopathy. Br Heart J 55:575–581
38. Fleiss JL (1971) Measuring nominal scale agreement among many raters. Psychol Bull 76:378–382
39. Bleul CC, Fuhlbrigge RC, Casasnovas JM, Aiuti A, Springer TA (1996) A highly efficacious lymphocyte chemoattractant, stromal cell-derived factor 1 (SDF-1). J Exp Med 184:1101–1109
40. Borst O, Schaub M, Walker B, Sauter M, Muenzer P, Gramlich M, Mueller K, Geisler T, Lang F, Klingel K, Kandolf R, Bigalke B, Gawaz M, Zuern CS (2014) CXCL16 is a novel diagnostic marker and predictor of mortality in inflammatory cardiomyopathy and heart failure. Int J Cardiol 176:896–903. doi:10.1016/j.ijcard.2014.08.033
41. Fuse K, Kodama M, Hanawa H, Okura Y, Ito M, Shiono T, Maruyama S, Hirono S, Kato K, Watanabe K, Aizawa Y (2001) Enhanced expression and production of monocyte chemoattractant protein-1 in myocarditis. Clin Exp Immunol 124:346–352
42. Leuschner F, Courties G, Dutta P, Mortensen LJ, Gorbatov R, Sena B, Novobrantseva TI, Borodovsky A, Fitzgerald K, Koteliansky V, Iwamoto Y, Bohlender M, Meyer S, Lasitschka F, Meder B, Katus HA, Lin C, Libby P, Swirski FK, Anderson DG, Weissleder R, Nahrendorf M (2014) Silencing of CCR2 in myocarditis. Eur Heart J. doi:10.1093/eurheartj/ehu225
43. Hohensinner PJ, Rychli K, Zorn G, Hulsmann M, Berger R, Mortl D, Richter B, Huber K, Wojta J, Pacher R, Niessner A (2010) Macrophage-modulating cytokines predict adverse outcome in heart failure. Thromb Haemost 103:435–441. doi:10.1160/TH09-06-0399
44. Goser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z (2005) Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Circulation 112:3400–3407. doi:10.1161/CIRCULATIONAHA.105.572396
45. Frangogiannis NG (2011) The stromal cell-derived factor-1/CXCR4 axis in cardiac injury and repair. J Am Coll Cardiol 58:2424–2426. doi:10.1016/j.jacc.2011.08.031
46. Liehn EA, Tuchscheerer N, Kanzler I, Drechsler M, Fraemohs L, Schuh A, Koenen RR, Zander S, Soehnlein O, Hristov M, Grigorescu G, Urs AO, Leabu M, Bucur I, Merx MW, Zernecke A, Ehling J, Gremse F, Lammers T, Kiessling F, Bernhagen J, Schober A, Weber C (2011) Double-edged role of the CXCL12/CXCR4 axis in experimental myocardial infarction. J Am Coll Cardiol 58:2415–2423. doi:10.1016/j.jacc.2011.08.033
47. Chu PY, Mariani J, Finch S, McMullen JR, Sadoshima J, Marshall T, Kaye DM (2010) Bone marrow-derived cells contribute to fibrosis in the chronically failing heart. Am J Pathol 176:1735–1742. doi:10.2353/ajpath.2010.090574
48. Ghio S, Gavazzi A, Campana C, Inserra C, Klersy C, Sebastiani R, Arbustini E, Recusani F, Tavazzi L (2001) Independent and additive prognostic value of right ventricular systolic function and pulmonary artery pressure in patients with chronic heart failure. J Am Coll Cardiol 37:183–188
49. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) (1999). Lancet 353:2001–2007
50. Van Linthout S, Miteva K, Tschope C (2014) Crosstalk between fibroblasts and inflammatory cells. Cardiovasc Res 102:258–269. doi:10.1093/cvr/cvu062
51. Westermann D, Lindner D, Kasner M, Zietsch C, Savvatis K, Escher F, von Schlippenbach J, Skurk C, Steendijk P, Riad A, Poller W, Schultheiss HP, Tschope C (2011) Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction. Circ Heart Fail 4:44–52. doi:10.1161/CIRCHEARTFAILURE.109.931451